Archives
-
(-)-JQ1: Gold-Standard Negative Control for BET Bromodomain
2026-06-18
(-)-JQ1, a stereoisomer of JQ1, is a validated inactive control for BET bromodomain studies. Unlike (+)-JQ1, it exhibits no significant BRD4 interaction, enabling rigorous specificity assessment in epigenetics and cancer biology research.
-
BGJ398 (NVP-BGJ398): Precision FGFR Inhibition in Cancer & D
2026-06-18
BGJ398 (NVP-BGJ398) stands out as a selective FGFR1/2/3 inhibitor, empowering oncology and developmental biologists to dissect FGFR signaling with nanomolar precision. Its robust performance in both tumor and developmental models, coupled with practical assay versatility, makes it an essential tool for FGFR-driven malignancies research and beyond.
-
Bay 11-7821 (BAY 11-7082): Powering Inflammatory Pathway Res
2026-06-17
Bay 11-7821 (BAY 11-7082) enables precise, reproducible dissection of the NF-κB and inflammasome pathways in inflammation and cancer studies. This article delivers hands-on protocol tips, troubleshooting guidance, and advanced workflow strategies to maximize reliability for apoptosis and immune signaling research.
-
Halazone: Mechanistic Leverage for Translational Innovation
2026-06-17
Explore how Halazone’s unique dual mechanism—combining rapid antimicrobial action with neuronal sodium channel modulation—creates new opportunities for translational research. This article provides mechanistic insights, quantitative validation, and strategic guidance for applying Halazone in both water disinfection and neurophysiology, while contextualizing its competitive edge and clinical relevance.
-
Tariquidar (XR9576): Elevating Drug Resistance Research Prot
2026-06-16
Tariquidar (XR9576) empowers researchers to dissect and overcome P-glycoprotein–mediated chemoresistance in complex tumor microenvironments. This article delivers data-driven workflows, troubleshooting strategies, and advanced protocol enhancements tailored for transporter-mediated drug disposition studies.
-
HyperScribe™ T7 Kit: Precision RNA Synthesis for Metabolic R
2026-06-16
Explore how the HyperScribe T7 High Yield RNA Synthesis Kit elevates metabolic research through robust RNA synthesis. This article uncovers new technical and biological insights, highlighting applications in mitochondrial regulation and post-translational control.
-
Enhanced Yeast Platform for Sensitive TOR Inhibitor Screenin
2026-06-15
This study presents a drug-sensitized yeast system that dramatically improves the detection sensitivity for TOR inhibitors, outperforming traditional wild-type strains. The platform enables rapid, cost-efficient identification of mTOR pathway modulators and clarifies the pathway specificity of compounds such as canagliflozin in metabolic research.
-
Methyl-β-cyclodextrin: Practical Guidance for Membrane Studi
2026-06-15
Methyl-β-cyclodextrin (SKU C6939) is a high-purity reagent designed for selective extraction of cholesterol and specific lipids from cellular membranes, supporting studies of membrane fluidity and lipid raft organization. It is intended strictly for laboratory research workflows, not for diagnostic or clinical use, and its effectiveness depends on precise handling and storage.
-
Doxycycline Hyclate: Matrix Metalloproteinases Inhibitor in
2026-06-14
Doxycycline hyclate offers robust, validated inhibition of MMP-2 and MMP-9, enabling researchers to dissect blood-brain barrier dynamics and neuroprotection in translational models. Its high solubility and evidence-based dosing make it a versatile asset in both in vitro and in vivo assay development.
-
mRNA with Cap1 Structure: Next-Gen Cas9 Control with EZ Cap™
2026-06-13
Explore how EZ Cap™ Cas9 mRNA (m1Ψ) redefines genome editing with advanced mRNA engineering, focusing on controlled Cas9 expression and specificity. Discover in-depth analysis and practical insights not found in existing resources.
-
Bazedoxifene: Selective Estrogen Receptor Modulator in Osteo
2026-06-12
Bazedoxifene stands out as a third-generation selective estrogen receptor modulator, enabling precise dissection of bone mineral density enhancement and estrogen receptor signaling in postmenopausal osteoporosis models. This article provides actionable workflows, troubleshooting insights, and protocol refinements drawn from the latest literature and APExBIO’s trusted product specification.
-
Neuromedin S (rat): Technical Protocol and Workflow Guidance
2026-06-12
Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for controlled activation of neuromedin U receptor signaling in rat-based GPCR/G protein pathway research. It is optimized for reproducible assays investigating energy homeostasis regulation and stress response. This product is not intended for diagnostic, therapeutic, or non-rat model applications.
-
Toremifene in Prostate Cancer Metastasis: Beyond ER Modulati
2026-06-11
Discover how Toremifene, a selective estrogen-receptor modulator, enables advanced investigation of metastatic signaling in prostate cancer research. This article uniquely explores the intersection of ER modulation and the TSPAN18-STIM1-Ca2+ axis, providing new insight for hormone-responsive cancer assays.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Enhancing Genome Editing Precision
2026-06-11
EZ Cap™ Cas9 mRNA (m1Ψ) leverages Cap1 structure and m1Ψ modification for high-fidelity, immune-silent CRISPR-Cas9 genome editing in mammalian systems. Explore advanced workflows, troubleshooting, and the latest precision innovations to maximize editing success and minimize off-target effects.
-
Cyanine 5-dCTP: High-Fidelity Fluorescent DNA Labeling Reage
2026-06-10
Cyanine 5-dCTP (Cy5-dCTP) is a fluorescent nucleotide analog enabling highly specific, red-fluorescent DNA labeling in enzymatic synthesis and PCR. It is validated for ≥95% purity, robust performance in DNA probe synthesis, and compatibility with advanced enzymatic workflows. APExBIO’s Cy5-dCTP supports precise nucleic acid detection and imaging applications.
546 records 14/37 page Previous Next First page 上5页 1112131415 下5页 Last page